Treatment of Iron Deficiency Anemia and Folate Deficiency in Young Children

Anemia is a global health problem worldwide associated with high morbidity and mortality rates and an increase in the number of hospitalizations. The article reflects the prevalence of grade 1 iron deficiency anemia and folate deficiency in children from 0 to 36 months of age, presents the latest data on the clinical efficacy of a drug containing iron protein succinylate and calcium folinate pentahydrate in this category of children in the treatment of grade 1 iron deficiency anemia and folate deficiency. The study monitored blood changes in children from 0 to 36 with grade 1 iron deficiency anemia and folate deficiency before and after treatment with a drug containing iron protein succinylate and calcium folinate pentagiomrate, and justified the pharmacoeconomical expediency of prescribing this drug from the point of view of the patient and the doctor.